Voyager Therapeutics Secures $165M Deal To Market Neurological Disorder Therapies.
January 30, 2019
The Boston Globe (1/29, Saltzman) reports Cambridge, Massachusetts-based Voyager Therapeutics has signed a deal with San Diego, California-based Neurocrine Biosciences to help Voyager “develop and market gene therapies for Parkinson’s disease and other se...